News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,795 Results
Type
Article (14846)
Company Profile (283)
Press Release (256666)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (80344)
Career Advice (155)
Deals (13345)
Drug Delivery (35)
Drug Development (51693)
Employer Resources (31)
FDA (5842)
Job Trends (5284)
News (146502)
Policy (10216)
Tag
Academia (955)
Accelerated approval (2)
Adcomms (14)
Allergies (52)
Alliances (21950)
ALS (64)
Alzheimer's disease (852)
Antibody-drug conjugate (ADC) (103)
Approvals (5865)
Artificial intelligence (128)
Autoimmune disease (18)
Automation (5)
Bankruptcy (106)
Best Places to Work (4706)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (233)
Bladder cancer (61)
Brain cancer (21)
Breast cancer (156)
Cancer (1576)
Cardiovascular disease (117)
Career advice (136)
Career pathing (2)
CAR-T (118)
Cell therapy (337)
Cervical cancer (9)
Clinical research (42104)
Collaboration (551)
Compensation (261)
Complete response letters (13)
COVID-19 (1042)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1554)
Denatured (11)
Depression (31)
Diabetes (139)
Diagnostics (1346)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (87)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (30230)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (49302)
Executive appointments (464)
FDA (6554)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (502)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (373)
Government (1128)
Grass and pollen (2)
Guidances (27)
Healthcare (6724)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (94)
Indications (20)
Infectious disease (1107)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (18)
IPO (7333)
IRA (11)
Job creations (873)
Job search strategy (129)
Kidney cancer (8)
Labor market (5)
Layoffs (220)
Leadership (3)
Legal (1394)
Liver cancer (44)
Lung cancer (226)
Lymphoma (106)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (54)
Medical device (2609)
Medtech (2610)
Mergers & acquisitions (6347)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1262)
NextGen: Class of 2025 (2049)
Non-profit (871)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (58)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (80)
Peanut (35)
People (25783)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14884)
Phase II (19559)
Phase III (12441)
Pipeline (832)
Policy (45)
Postmarket research (858)
Preclinical (6270)
Press Release (30)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (292)
Real estate (1427)
Recruiting (12)
Regulatory (8799)
Reports (15)
Research institute (987)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (101)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (14)
Startups (1985)
State (1)
Stomach cancer (7)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (226)
Venture capitalists (32)
Weight loss (110)
Women's health (16)
Worklife (2)
Date
Today (99)
Last 7 days (522)
Last 30 days (1556)
Last 365 days (19856)
2025 (6419)
2024 (20830)
2023 (22765)
2022 (27254)
2021 (28265)
2020 (23778)
2019 (16605)
2018 (11990)
2017 (14080)
2016 (12096)
2015 (14564)
2014 (10481)
2013 (7508)
2012 (7561)
2011 (7621)
2010 (7431)
Location
Africa (149)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17649)
Australia (2992)
California (3908)
Canada (1148)
China (366)
Colorado (150)
Connecticut (152)
Delaware (106)
Europe (37985)
Florida (476)
Georgia (117)
Idaho (16)
Illinois (239)
India (11)
Indiana (93)
Iowa (2)
Japan (77)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (487)
Massachusetts (3116)
Michigan (71)
Minnesota (145)
Mississippi (1)
Missouri (29)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1017)
New Mexico (12)
New York (1057)
North Carolina (559)
North Dakota (5)
Northern California (1723)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (744)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (4)
Southern California (1507)
Tennessee (25)
Texas (458)
United States (13484)
Utah (53)
Virginia (84)
Washington D.C. (30)
Washington State (358)
Wisconsin (15)
271,795 Results for "checkpoint therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Press Releases
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
March 31, 2025
·
18 min read
Press Releases
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
April 29, 2025
·
6 min read
Press Releases
Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
March 19, 2025
·
7 min read
Press Releases
Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting
March 31, 2025
·
6 min read
Press Releases
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
March 17, 2025
·
6 min read
Press Releases
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
December 16, 2024
·
15 min read
Genetown
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
Checkpoint Therapeutics, Inc. today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its biologics license application (“BLA”) resubmission strategy for cosibelimab.
June 24, 2024
·
5 min read
GLP-1
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences suggest history may not repeat itself.
March 19, 2025
·
8 min read
·
Ben Hargreaves
Press Releases
SparX to Present Phase 1 Clinical Updates of SPX-303, a Dual Checkpoint Bispecific Antibody, at Two Events During AACR 2025
April 18, 2025
·
3 min read
1 of 27,180
Next
